Big 4 Private Equity Firms In Brighter Mood; Falling Investment In Biotech
Private equity fundraising struggled in 2024, with total capital raised declining for the third consecutive year. Read more ...
Trinity Biotech (NASDAQ:TRIB) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of Trinity Biotech (NASDAQ:TRIB – Free Report) in a research note released on Friday morning. The firm issued a hold rating on the stock. Trinity Biotech Price ...
Investing16d
Trinity Biotech reports leap in CGM system accuracy
DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), a leader in diabetes management solutions currently trading at $0.86 per share, has announced significant enhancements in the performance of its continuous ...
Hosted on MSN17d
Trinity Biotech’s CGM System Shows Breakthrough Improvements
Trinity Biotech ( (TRIB)) has shared an update. On February 6, 2025, Trinity Biotech announced significant improvements in its continuous glucose monitoring (CGM) system, following its latest pre ...
Nasdaq17d
Trinity Biotech Reveals New Findings From Pre-Pivotal Trial Of Next-Gen CGM
(RTTNews) - Trinity Biotech plc (TRIB), a biotechnology company focused on diabetes management, on Thursday announced notable advances in its pre-pivotal trial for its next-generation continuous ...
Finanznachrichten17d
Trinity Biotech plc: Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
Zeit Aktuelle Nachrichten 11.02. Trinity Biotech-Aktie erreicht 52-Wochen-Tief bei 0,74 US-Dollar 06.02. TRINITY BIOTECH PLC - 6-K, Report of foreign issuer 06.02. Trinity Biotech reports leap in ...
Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
The latest analysis confirms that first-day accuracy - a critical performance metric for CGM users - shows an approximately 35% improvement in Mean Absolute Relative Difference (MARD) and a more than ...